Symbols / CG Stock $45.32 -0.44% The Carlyle Group Inc.
CG (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteThe Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in management-led/ Leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and venture and growth capital financings, seed/startup, early venture, emerging growth, turnaround, mid venture, late venture, PIPES, recapitalization. The firm invests across four segments which include Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions. The firm typically invests in industrial, agribusiness, ecological sector, fintech, airports, parking, Plastics, Rubber, diversified natural resources, minerals, farming, aerospace, defense, automotive, consumer, retail, industrial, infrastructure, energy, power, healthcare, software, software enabled services, semiconductors, communications infrastructure, financial technology, utilities, gaming, systems and related supply chain, electronic systems, systems, oil and gas, processing facilities, power generation assets, technology, systems, real estate, financial services, transportation, business services, telecommunications, media, and logistics sectors. Within the industrial sector, the firm invests in manufacturing, building products, packaging, chemicals, metals and mining, forestry and paper products, and industrial consumables and services. In consumer and retail sectors, it invests in food and beverage, retail, restaurants, consumer products, domestic consumption, consumer services, personal care products, direct marketing, and education. Within aerospace, defense, business services, and government services sectors, it seeks to invest in defense electronics, manufacturing and services, government contracting and services, information technology, distribution companies, supply chains, aftermarket services, cybersecurity and digital resilience, digital transformation. Within healthcare, biotech and medtech innovation, life sciences, healthcare IT, pharmacy, pharma commercialization. In telecommunication and media sectors, it invests in cable TV, directories, publishing, entertainment and content delivery services, wireless infrastructure/services, fixed line networks, satellite services, broadband and Internet, and infrastructure. Within real estate, the firm invests in office, hotel, industrial, retail, for sale residential, student housing, hospitality, multifamily residential, homebuilding and building products, and senior living sectors. The firm seeks to make investments in growing business including those with overleveraged balance sheets. The firm seeks to hold its investments for four to six years. In the healthcare sector, it invests in healthcare services, outsourcing services, companies running clinical trials for pharmaceutical companies, managed care, pharmaceuticals, pharmaceutical related services, healthcare IT, medical, products, and devices. It seeks to invest in companies based in Sub-Saharan focusing on Ghana, Kenya, Mozambique, Botswana, Nigeria, Uganda, West Africa, North Africa and South Africa focusing on Tanzania and Zambia; Asia focusing on Pakistan, India, Hong Kong, South East Asia, Indonesia, Philippines, Malaysia, Singapore, Vietnam, Taiwan, Korea, and Japan; Australia; New Zealand; Europe focusing on France, Italy, Denmark, United Kingdom, Germany, Austria, Belgium, Finland, Iceland, Ireland, Netherlands, Norway, Portugal, Spain, Benelux , Sweden, Switzerland, Hungary, Poland, and Russia; Middle East focusing on Bahrain, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Turkey, and UAE; North America focusing on United States which further invest in Southeastern United States, Texas, Boston, San Francisco Bay Area and Pacific Northwest; Asia Pacific; Soviet Union, Central-Eastern Europe, and Israel; Nordic region; and South America focusing on Mexico, Argentina, Brazil, Chile, and Peru. The firm seeks to invest in food, financial, and healthcare industries in Western China. In the real estate sector, the firm seeks to invest in various locations across Europe focusing on France and Central Europe, United States, Asia focusing on China, and Latin America. It typically invests between $2.24 million and $50 million for venture investments and between $50 million and $2 billion for buyouts in companies with enterprise value of between $31.57 million and $1000 million and sales value of $50 million and $300 million. It seeks to invest in companies with market capitalization greater than $50 million and EBITDA between $5 million to $25 million. It prefers to take a majority or a minority stake. While investing in Japan, it does not invest in companies with more than 1,000 employees and prefers companies' worth between $100 million and $150 million. The firm originates, structures, and acts as lead equity investor in the transactions. The Carlyle Group Inc. was founded in 1987 and is based in Washington, District of Columbia with additional offices across North America, South America, Asia, Australia and Europe.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-05-18 | main | TD Cowen | Hold → Hold | $50 |
| 2026-05-08 | down | TD Cowen | Buy → Hold | $53 |
| 2026-05-08 | main | JP Morgan | Neutral → Neutral | $63 |
| 2026-05-08 | main | Barclays | Overweight → Overweight | $63 |
| 2026-04-30 | main | JP Morgan | Neutral → Neutral | $66 |
| 2026-04-21 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $66 |
| 2026-04-21 | main | Evercore ISI Group | In-Line → In-Line | $56 |
| 2026-04-08 | main | Barclays | Overweight → Overweight | $67 |
| 2026-04-07 | main | Goldman Sachs | Buy → Buy | $69 |
| 2026-03-24 | main | BMO Capital | Outperform → Outperform | $58 |
| 2026-03-02 | main | Barclays | Overweight → Overweight | $68 |
| 2026-02-27 | main | TD Cowen | Buy → Buy | $67 |
| 2026-02-27 | main | RBC Capital | Outperform → Outperform | $69 |
| 2026-02-24 | init | RBC Capital | — → Outperform | $67 |
| 2026-02-20 | main | UBS | Buy → Buy | $65 |
| 2026-02-10 | main | JP Morgan | Neutral → Neutral | $67 |
| 2026-02-09 | main | Barclays | Overweight → Overweight | $71 |
| 2026-01-22 | main | Evercore ISI Group | In-Line → In-Line | $62 |
| 2026-01-14 | main | TD Cowen | Buy → Buy | $76 |
| 2026-01-13 | main | UBS | Buy → Buy | $81 |
News
RSS: Latest CG news- Algebris UK Ltd. Invests $50.46 Million in Carlyle Group Inc. $CG - MarketBeat hu, 21 May 2026 07
- Private markets move into retirement plans as AB, Brookfield, Carlyle unite - Stock Titan Wed, 20 May 2026 11
- Analysts Are More Bearish On The Carlyle Group Inc. (NASDAQ:CG) Than They Used To Be - simplywall.st Wed, 20 May 2026 10
- UBS reiterates Buy on CG Oncology stock, cites combo trial data - Investing.com Mon, 18 May 2026 15
- Trade Spotlight: How should you trade Granules, Tata Motors Passenger Vehicles, CG Power, Cummins India, Hindalco, and others on May 21? - TradingView hu, 21 May 2026 01
- CG Price Today: The Carlyle Group Inc. Stock Price, Quote & Chart | MEXC - MEXC Mon, 18 May 2026 12
- Asset Management Stocks Q1 Highlights: Carlyle (NASDAQ:CG) - Yahoo Finance UK Sun, 17 May 2026 19
- CG Maintained by TD Cowen -- Price Target Lowered to $50 - GuruFocus Mon, 18 May 2026 18
- Carlyle (NASDAQ:CG) Misses Q1 CY2026 Sales Expectations, Stock Drops - StockStory hu, 07 May 2026 07
- TD Cowen Has Lowered Expectations for Carlyle Group (NASDAQ:CG) Stock Price - MarketBeat Mon, 18 May 2026 16
- Bladder cancer grants back AI biomarker, price transparency research - Stock Titan ue, 19 May 2026 12
- A Look At Carlyle Group (CG) Valuation After Disappointing First Quarter Earnings - Yahoo Finance Sat, 16 May 2026 23
- TimesSquare Capital Management LLC Decreases Stock Holdings in CG Oncology, Inc. $CGON - MarketBeat Wed, 20 May 2026 11
- Assessing CG Oncology (CGON) Valuation After Strong Phase 2 CORE 008 Cohort CX Trial Data - simplywall.st Sun, 17 May 2026 18
- Why Is Carlyle (CG) Stock Rocketing Higher Today - Yahoo Finance hu, 26 Feb 2026 08
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
3,213.20
-5.56%
|
3,402.40
+156.94%
|
1,324.20
-60.53%
|
3,355.30
|
| Operating Revenue |
|
3,213.20
-5.56%
|
3,402.40
+156.94%
|
1,324.20
-60.53%
|
3,355.30
|
| Operating Expense |
|
2,054.00
+2.26%
|
2,008.70
+4.34%
|
1,925.10
+7.98%
|
1,782.80
|
| Selling General And Administration |
|
784.30
+17.83%
|
665.60
+2.07%
|
652.10
+13.25%
|
575.80
|
| General And Administrative Expense |
|
784.30
+17.83%
|
665.60
+2.07%
|
652.10
+13.25%
|
575.80
|
| Other Operating Expenses |
|
-0.20
+33.33%
|
-0.30
-250.00%
|
0.20
-80.00%
|
1.00
|
| Reconciled Depreciation |
|
192.10
+4.35%
|
184.10
+1.94%
|
180.60
+22.52%
|
147.40
|
| Net Income |
|
808.70
-20.75%
|
1,020.40
+267.72%
|
-608.40
-149.67%
|
1,225.00
|
| Pretax Income |
|
1,159.20
-16.83%
|
1,393.70
+331.94%
|
-600.90
-138.21%
|
1,572.50
|
| Net Interest Income |
|
44.70
-59.33%
|
109.90
-39.48%
|
181.60
+88.77%
|
96.20
|
| Interest Expense |
|
748.20
+9.08%
|
685.90
+26.34%
|
542.90
+68.60%
|
322.00
|
| Interest Income |
|
792.90
-0.36%
|
795.80
+9.84%
|
724.50
+73.24%
|
418.20
|
| Gain On Sale Of Security |
|
117.90
+391.25%
|
24.00
+247.83%
|
6.90
+116.63%
|
-41.50
|
| Tax Provision |
|
214.50
-29.11%
|
302.60
+390.40%
|
-104.20
-136.21%
|
287.80
|
| Tax Rate For Calcs |
|
0.00
-14.75%
|
0.00
+25.43%
|
0.00
-5.46%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
944.70
-13.42%
|
1,091.10
+319.67%
|
-496.70
-138.66%
|
1,284.70
|
| Net Income From Continuing Operation Net Minority Interest |
|
808.70
-20.75%
|
1,020.40
+267.72%
|
-608.40
-149.67%
|
1,225.00
|
| Net Income From Continuing And Discontinued Operation |
|
808.70
-20.75%
|
1,020.40
+267.72%
|
-608.40
-149.67%
|
1,225.00
|
| Net Income Continuous Operations |
|
944.70
-13.42%
|
1,091.10
+319.67%
|
-496.70
-138.66%
|
1,284.70
|
| Minority Interests |
|
-136.00
-92.36%
|
-70.70
+36.71%
|
-111.70
-87.10%
|
-59.70
|
| Normalized Income |
|
808.70
-20.75%
|
1,020.40
+267.72%
|
-608.40
-149.67%
|
1,225.00
|
| Net Income Common Stockholders |
|
808.70
-20.75%
|
1,020.40
+267.72%
|
-608.40
-149.67%
|
1,225.00
|
| Diluted EPS |
|
—
|
2.77
+264.88%
|
-1.68
-150.15%
|
3.35
|
| Basic EPS |
|
—
|
2.85
+269.64%
|
-1.68
-149.56%
|
3.39
|
| Basic Average Shares |
|
—
|
358.60
-0.77%
|
361.40
+0.03%
|
361.28
|
| Diluted Average Shares |
|
—
|
368.00
+1.83%
|
361.40
-1.18%
|
365.71
|
| Diluted NI Availto Com Stockholders |
|
808.70
-20.75%
|
1,020.40
+267.72%
|
-608.40
-149.67%
|
1,225.00
|
| Preferred Stock Dividends |
|
—
|
—
|
—
|
—
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
21,176.00
|
| Cash And Cash Equivalents |
|
1,786.30
|
| Receivables |
|
832.60
|
| Prepaid Assets |
|
—
|
| Net PPE |
|
493.70
|
| Goodwill And Other Intangible Assets |
|
766.10
|
| Goodwill |
|
104.00
|
| Other Intangible Assets |
|
662.10
|
| Investments And Advances |
|
17,208.40
|
| Long Term Equity Investment |
|
3,024.10
|
| Total Liabilities Net Minority Interest |
|
15,391.50
|
| Payables |
|
275.90
|
| Accounts Payable |
|
—
|
| Other Payable |
|
275.90
|
| Long Term Debt And Capital Lease Obligation |
|
9,255.60
|
| Stockholders Equity |
|
5,191.40
|
| Common Stock Equity |
|
5,191.40
|
| Capital Stock |
|
3.60
|
| Common Stock |
|
3.60
|
| Share Issued |
|
361.33
|
| Ordinary Shares Number |
|
361.33
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
3,403.00
|
| Retained Earnings |
|
2,082.10
|
| Minority Interest |
|
593.10
|
| Total Equity Gross Minority Interest |
|
5,784.50
|
| Total Capitalization |
|
13,958.90
|
| Invested Capital |
|
13,958.90
|
| Total Debt |
|
9,255.60
|
| Net Debt |
|
6,981.20
|
| Net Tangible Assets |
|
4,425.30
|
| Tangible Book Value |
|
4,425.30
|
| Available For Sale Securities |
|
14,184.30
|
| Cash Cash Equivalents And Federal Funds Sold |
|
1,788.10
|
| Investmentin Financial Assets |
|
14,184.30
|
| Trading Securities |
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-3,275.50
-331.27%
|
-759.50
-470.67%
|
204.90
+154.02%
|
-379.30
|
| Net Income From Continuing Operations |
|
944.70
-13.42%
|
1,091.10
+319.67%
|
-496.70
-138.66%
|
1,284.70
|
| Depreciation |
|
192.10
+4.35%
|
184.10
+1.94%
|
180.60
+22.52%
|
147.40
|
| Depreciation And Amortization |
|
192.10
+4.35%
|
184.10
+1.94%
|
180.60
+22.52%
|
147.40
|
| Other Non Cash Items |
|
-0.60
-100.37%
|
162.00
-92.13%
|
2,058.50
+1197.10%
|
158.70
|
| Gain Loss On Investment Securities |
|
-4,968.00
-131.22%
|
-2,148.60
-129.62%
|
-935.70
+26.10%
|
-1,266.10
|
| Change In Working Capital |
|
559.00
+1370.45%
|
-44.00
+91.75%
|
-533.20
+23.64%
|
-698.30
|
| Change In Receivables |
|
94.90
+174.67%
|
-127.10
-100.16%
|
-63.50
-0.47%
|
-63.20
|
| Change In Prepaid Assets |
|
-41.00
-582.35%
|
8.50
+34.92%
|
6.30
+153.39%
|
-11.80
|
| Change In Accrued Expense |
|
95.10
+356.33%
|
-37.10
-450.00%
|
10.60
+107.83%
|
-135.40
|
| Change In Payable |
|
176.70
+275.16%
|
47.10
+198.74%
|
-47.70
-278.57%
|
-12.60
|
| Change In Other Current Assets |
|
119.30
+122.67%
|
-526.30
-206.34%
|
-171.80
-181.64%
|
-61.00
|
| Change In Other Current Liabilities |
|
114.00
-80.71%
|
590.90
+321.23%
|
-267.10
+35.53%
|
-414.30
|
| Investing Cash Flow |
|
-99.40
-28.09%
|
-77.60
-77.98%
|
-43.60
+94.74%
|
-828.80
|
| Net PPE Purchase And Sale |
|
-99.40
-27.93%
|
-77.70
-16.67%
|
-66.60
+89.89%
|
-659.00
|
| Purchase Of PPE |
|
-99.40
-27.93%
|
-77.70
-16.67%
|
-66.60
+89.89%
|
-659.00
|
| Capital Expenditure |
|
-99.40
-27.93%
|
-77.70
-16.67%
|
-66.60
+89.89%
|
-659.00
|
| Net Investment Purchase And Sale |
|
0.00
-100.00%
|
0.10
-99.57%
|
23.00
+217.35%
|
-19.60
|
| Purchase Of Investment |
|
0.00
+100.00%
|
-5.00
+97.33%
|
-187.30
-169.11%
|
-69.60
|
| Sale Of Investment |
|
0.00
-100.00%
|
5.10
-97.57%
|
210.30
+320.60%
|
50.00
|
| Net Business Purchase And Sale |
|
—
|
0.00
|
0.00
+100.00%
|
-150.20
|
| Purchase Of Business |
|
—
|
0.00
|
0.00
+100.00%
|
-150.20
|
| Financing Cash Flow |
|
3,990.40
+484.42%
|
682.80
+785.54%
|
-99.60
-186.76%
|
114.80
|
| Net Issuance Payments Of Debt |
|
4,840.90
+183.89%
|
1,705.20
+145.21%
|
695.40
+2.16%
|
680.70
|
| Issuance Of Debt |
|
4,897.40
+166.73%
|
1,836.10
+157.66%
|
712.60
+2.18%
|
697.40
|
| Repayment Of Debt |
|
-56.50
+56.84%
|
-130.90
-661.05%
|
-17.20
-2.99%
|
-16.70
|
| Long Term Debt Issuance |
|
4,897.40
+166.73%
|
1,836.10
+157.66%
|
712.60
+2.18%
|
697.40
|
| Long Term Debt Payments |
|
-56.50
+56.84%
|
-130.90
-661.05%
|
-17.20
-2.99%
|
-16.70
|
| Net Long Term Debt Issuance |
|
4,840.90
+183.89%
|
1,705.20
+145.21%
|
695.40
+2.16%
|
680.70
|
| Net Common Stock Issuance |
|
-686.50
-23.78%
|
-554.60
-172.53%
|
-203.50
-38.72%
|
-146.70
|
| Common Stock Payments |
|
-686.50
-23.78%
|
-554.60
-172.53%
|
-203.50
-9.64%
|
-185.60
|
| Common Stock Dividend Paid |
|
-505.10
-0.42%
|
-503.00
-1.06%
|
-497.70
-12.20%
|
-443.60
|
| Cash Dividends Paid |
|
-505.10
-0.42%
|
-503.00
-1.06%
|
-497.70
-12.20%
|
-443.60
|
| Repurchase Of Capital Stock |
|
-686.50
-23.78%
|
-554.60
-172.53%
|
-203.50
-9.64%
|
-185.60
|
| Net Other Financing Charges |
|
341.10
+869.03%
|
35.20
+137.53%
|
-93.80
-484.43%
|
24.40
|
| Changes In Cash |
|
615.50
+498.90%
|
-154.30
-350.08%
|
61.70
+105.64%
|
-1,093.30
|
| Effect Of Exchange Rate Changes |
|
91.60
+530.05%
|
-21.30
-212.70%
|
18.90
+193.10%
|
-20.30
|
| Beginning Cash Position |
|
1,266.50
-12.18%
|
1,442.10
+5.92%
|
1,361.50
-44.99%
|
2,475.10
|
| End Cash Position |
|
1,973.60
+55.83%
|
1,266.50
-12.18%
|
1,442.10
+5.92%
|
1,361.50
|
| Free Cash Flow |
|
-3,374.90
-303.12%
|
-837.20
-705.35%
|
138.30
+113.32%
|
-1,038.30
|
| Common Stock Issuance |
|
—
|
0.00
|
0.00
-100.00%
|
38.90
|
| Issuance Of Capital Stock |
|
—
|
0.00
|
0.00
-100.00%
|
38.90
|
| Net Preferred Stock Issuance |
|
—
|
—
|
—
|
—
|
| Preferred Stock Dividend Paid |
|
—
|
—
|
—
|
—
|
| Preferred Stock Payments |
|
—
|
—
|
—
|
—
|
| Sale Of Business |
|
—
|
—
|
0.00
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 10-Q2026-05-08 View
- 8-K2026-05-07 View
- 42026-05-01 View
- 42026-05-01 View
- 42026-05-01 View
- 42026-05-01 View
- 42026-05-01 View
- 42026-05-01 View
- 42026-05-01 View
- 42026-05-01 View
- 42026-05-01 View
- 42026-03-20 View
- 42026-03-12 View
- 42026-03-06 View
- 42026-03-02 View
- 10-K2026-02-27 View
- 8-K2026-02-26 View
- 42026-02-20 View
- 42026-02-20 View
- 42026-02-20 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|